Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer

Immunotherapies, such as immune-checkpoint blockade and adoptive T-cell therapy, offer novel treatment options with good efficacy for patients with urothelial bladder cancer. However, heterogeneity and therapeutic resistance have limited the use of immunotherapy. Further research into immune-regulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tianhang, Liu, Tianyao, Zhao, Zihan, Pan, Yuchen, Xu, Xinyan, Zhang, Yulin, Zhan, Shoubin, Zhou, Shengkai, Zhu, Wenjie, Guo, Hongqian, Yang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483128/
https://www.ncbi.nlm.nih.gov/pubmed/36131933
http://dx.doi.org/10.3389/fimmu.2022.911325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483128/
https://www.ncbi.nlm.nih.gov/pubmed/36131933
http://dx.doi.org/10.3389/fimmu.2022.911325

Ejemplares similares